Market›Health Care›Pharmaceuticals›Pharmaceuticals
CRESCITA THERAPEUTIC

CRRTF

$0.55Apr 28, 2021 – Apr 27, 2026
Health CarePharmaceuticals$10M
MVM
+$0.0M

Every news event mapped to its market reaction — 37 events, 61 months of data. No predictions, just what happened.

PositiveNegativeNo data· Dot size = magnitude · Scroll to zoom · Drag to pan
Hover to inspect

Want the full written briefing?

The chart shows what moved — the briefing shows why. Sourced, dated, no hot takes.

Subscribe on Substack →

News Events

DateReturnCategorySourceHeadline
2024-06-20+437.2%M&ASeeking AlphaCrescita to acquire strategic assets of Occy Laboratory
2026-03-16+61.4%newsMT NewswiresCrescita Therapeutics Up More Than 50% On Offer From ClinActive Holdings
2026-03-16+61.4%M&ABusiness WireCrescita Announces Definitive Agreement to Be Acquired by ClinActiv Holdings in an All-Cash Transaction at a Significant Premium
2026-03-16+61.4%M&ASeeking AlphaCrescita to be acquired by ClinActiv Holdings in an all-cash transaction
2026-03-16+61.4%M&ABusiness WireCrescita Announces Definitive Agreement to Be Acquired by ClinActiv Holdings in an All-Cash Transaction at a Significant Premium - Business Wire
2022-03-23+38.0%earningsSeeking AlphaCrescita Therapeutics GAAP EPS of C$0.04, revenue of C$7.56M
2023-11-08-27.6%earningsSeeking AlphaCrescita Therapeutics GAAP EPS of -C$0.06, revenue of C$3.03M
2022-05-11+19.3%earningsSeeking AlphaCrescita Therapeutics GAAP EPS of -C$0.02, revenue of C$4.95M
2022-08-10+15.4%earningsSeeking AlphaCrescita Therapeutics GAAP EPS of C$0.00, revenue of C$6.51M
2025-11-05+9.9%earningsSeeking AlphaCrescita Therapeutics GAAP EPS of $0.04, revenue of $5.39M
2021-11-11-6.4%earningsSeeking AlphaCrescita Therapeutics reports Q3 results
2022-05-05+5.4%newsSeeking AlphaCrescita Therapeutics (CRRTF) Investor Presentation - Slideshow
2021-09-09+4.6%expansionSeeking AlphaCrescita inks exclusive Canadian distribution agreement with Obagi Cosmeceuticals
2021-09-09+4.6%expansionBusiness WireCrescita Announces Exclusive Canadian Distribution Agreement with Obagi Cosmeceuticals LLC - Business Wire
2026-03-31-3.7%earningsMT NewswiresCrescita Therapeutics Q4 Loss Widens
2026-03-31-3.7%earningsBusiness WireCrescita Reports Q4 and Fiscal 2025 Results
2026-03-31-3.7%earningsThe Globe and MailCrescita Reports Q4 and Fiscal 2025 Results - The Globe and Mail
2022-11-09-3.3%earningsSeeking AlphaCrescita Therapeutics GAAP EPS of C$0.01, revenue of C$6.03M
2024-11-06-3.3%earningsSeeking AlphaCrescita Therapeutics GAAP EPS of -C$0.05, revenue of C$3.59M
2024-08-08-2.8%earningsSeeking AlphaCrescita Therapeutics GAAP EPS of -C$0.05, revenue of C$4.09M
2021-08-11+2.4%earningsSeeking AlphaCrescita Therapeutics reports Q2 results
2023-08-29-1.9%newsSeeking AlphaCrescita Therapeutics announces approval of normal course issuer bid
2021-05-11+1.8%earningsSeeking AlphaCrescita Therapeutics reports Q1 results
2026-04-22+1.4%newsBusiness WireCrescita Announces Filing and Mailing of Special Meeting Materials and Receipt of Interim Order in respect of Arrangement with ClinActiv Holdings
2026-04-22+1.4%newsThe AI JournalCrescita Announces Filing and Mailing of Special Meeting Materials and Receipt of Interim Order in respect of Arrangement with ClinActiv Holdings - The AI Journal
2025-05-23-1.4%expansionBusiness WireCrescita Therapeutics Announces Mutual Termination of Licensing Agreement with Croma Pharma GmbH for Pliaglis - Business Wire
2024-03-14+1.2%earningsSeeking AlphaCrescita Therapeutics reports Q4 results
2023-03-15-1.1%earningsSeeking AlphaCrescita Therapeutics GAAP EPS of C$0.06, revenue of C$6M
2021-08-18+0.9%expansionSeeking AlphaCrescita Therapeutics and STADA ink exclusive licensing agreement for pliaglis
2024-07-22-0.9%earningsSeeking AlphaCrescita secures four-year term contract manufacturing revenue from largest CMO client
2024-07-22-0.9%earningsBusiness WireCrescita Secures Contract Manufacturing Revenue of $US10 Million Over 4 Years - Business Wire
2025-03-19-0.8%earningsSeeking AlphaCrescita Therapeutics GAAP EPS of -C$0.01, revenue of C$6.9M
2023-08-09+0.6%earningsSeeking AlphaCrescita Therapeutics GAAP EPS of -C$0.01, revenue of C$5.2M
2025-05-14-0.6%earningsSeeking AlphaCrescita Therapeutics reports Q1 results
2024-05-08-0.6%earningsSeeking AlphaCrescita Therapeutics GAAP EPS of -C$0.03, revenue of C$4.9M
2024-07-19-0.4%newsSeeking AlphaLeading Canadian healthcare services provider selects Crescita as exclusive manufacturing partner
2023-05-11+0.3%earningsSeeking AlphaCrescita Therapeutics GAAP EPS of -C$0.01, revenue of C$4.6M
tickerdossier.comtickerdossier.substack.com